glp 1 agonist equivalent doses Practice Nurse Glucometabolic outcomes of GLP-1 receptor

Purpose of Review This review explores the role of GLP-1 receptor agonists (GLP-1 RAs) in addressing metabolic dysfunction and neurodegeneration in Parkinsons disease (PD), focusing on body weight regulation and neuroprotection

Best results are achieved alongside a healthy diet and consistent exercise

Promotes a healthy blood sugar response*: Reducose slows down the breakdown of carbs to reduce post-meal glucose spikes by up to 40%, while Feiolix supports insulin sensitivity and glucose metabolism.

Compliance-first.

These effects extend beyond weight loss, suggesting anti-inflammatory mechanisms with broad potential for managing chronic diseases.